Muscarinic Receptor Signaling in Asthma and COPD
Author Information
Author(s): Gosens Reinoud, Zaagsma Johan, Meurs Herman, Halayko Andrew J
Primary Institution: Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands
Hypothesis
Acetylcholine, acting through muscarinic receptors, may contribute significantly to the pathophysiology of asthma and COPD.
Conclusion
The review suggests that anticholinergics, particularly tiotropium bromide, could reduce airway remodeling and lung function decline in asthma and COPD patients.
Supporting Evidence
- Acetylcholine is produced not only by nerves but also by airway epithelial and inflammatory cells.
- Muscarinic receptors are involved in regulating airway smooth muscle contraction and mucus production.
- Tiotropium bromide has been shown to inhibit the decline of lung function in COPD patients.
Takeaway
This study talks about how a chemical called acetylcholine affects breathing problems like asthma and COPD, and how a medicine called tiotropium can help people breathe better.
Methodology
The review summarizes established and novel aspects of muscarinic receptor signaling in relation to asthma and COPD.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website